Abstract
Relapsing polychondritis (RP) is a rare disease of unknown etiology characterized by recurrent episodes of inflammation resulting in the destruction of cartilaginous tissues. We describe a young girl with RP unresponsive to conventional therapy.
References
Jaksch-Wartenhorst R (1923) Polychondropathia. Wien Arch F Inn Med 6:93–100
Letko E, Zafirakis P, Baltatzis S, Voudouri A, Livir-Rallatos C, Foster CS (2002) Relapsing polychondritis: a clinical review. Semin Arthritis Rheum 31:384–395. doi:10.1053/sarh.2002.32586
McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55:193–215. doi:10.1097/00005792-197605000-00001
Michet CJ Jr, McKenna CH, Luthra HS, O’Fallon WM (1986) Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 104:4–78
Yamaoka K, Saito K, Hanami K, Nakayamada S, Nawata M, Iwata S, Azuma T, Tanaka Y (2007) A case of life-threatening refractory polychondritis successfully treated with combined intensive immunosuppressive therapy with methotrexate. Mod Rheumatol 17(2):144–147. doi:10.1007/s10165-006-0548-5
Ormerod AD, Clark LJ (1992) Relapsing polychondritis—treatment with cyclosporin A. Br J Dermatol 127(3):300. doi:10.1111/j.1365-2133.1992.tb00135.x
Saadoun D, Deslandre CJ, Allanore Y, Pham XV, Kahan A (2003) Sustained response to infliximab in 2 patients with refractory relapsing polychondritis. J Rheumatol 30:1394–1395
Mpofu C, Estrach C, Curtis J, Moots RJ (2003) Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab. Rheumatology 42:1117–1118. doi:10.1093/rheumatology/keg280
Richez C, Dumoulin C, Coutouly X, Schaeverbeke T (2004) Successful treatment of relapsing polychondritis with infliximab. Clin Exp Rheumatol 22:629–631
Vounotrypidis P, Sakellariou GT, Zisopoulos D, Berberidis C (2006) Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra). Rheumatology (Oxford) 45(4):491–492. doi:10.1093/rheumatology/kel041
Wendling D, Govindaraju S, Prati C, Toussirot E, Bertolini E (2008) Efficacy of anakinra in a patient with refractory relapsing polychondritis. Jt Bone Spine 75(5):622–624. doi:10.1016/j.jbspin.2008.02.011
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buonuomo, P.S., Bracaglia, C., Campana, A. et al. Relapsing polychondritis: new therapeutic strategies with biological agents. Rheumatol Int 30, 691–693 (2010). https://doi.org/10.1007/s00296-009-0981-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-0981-9